NYBCe and Chan Zuckerberg Biohub collaborate to build iPSC platform from cord blood for regenerative medicine

Most of the umbilical cord blood collected at birth is discarded. The tissue is clamped, cut, and disposed of as medical waste, along with the stem cells it contains, cells that are immunologically naive, genetically diverse, and capable of being reprogrammed into virtually any cell type in the human body. The New York Blood Center […] This story continues at The Next Web